Gifts in Wills fund one-third of Cancer Research UK’s work; work that supports life-saving trials for people like Alfred.

The Cancer Research UK Centre for Drug Development has been pioneering the development of new cancer treatments for 30 years, taking over 160 potential new anti-cancer agents into clinical trials in ...

the prostate cancer drug abiraterone, and the HIV medicine lamivudine. The latter was marked up to quadruple of what the so-called "Big 3 PBMs" paid for it, the FTC found. Overall, the "Big 3 PBMs ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

the prostate cancer drug abiraterone, and the HIV medicine lamivudine. The latter was marked up to quadruple of what the so-called "Big 3 PBMs" paid for it, the FTC found. Overall, the "Big 3 PBMs" ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...